share_log

Universal Health Servs Analyst Ratings

Universal Health Servs Analyst Ratings

環球健康服務分析師評級
Benzinga ·  2023/09/14 11:52
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/14/2023 16.89% Cantor Fitzgerald → $148 Reiterates Underweight → Underweight
07/27/2023 33.48% Credit Suisse $163 → $169 Maintains Outperform
07/26/2023 22.42% Stephens & Co. → $155 Reiterates Equal-Weight → Equal-Weight
07/11/2023 34.27% Mizuho $150 → $170 Maintains Buy
06/02/2023 28.74% B of A Securities → $163 Assumes Neutral → Buy
05/16/2023 9.79% Goldman Sachs $124 → $139 Maintains Sell
05/16/2023 18.47% Mizuho $140 → $150 Maintains Buy
05/08/2023 21.63% TD Cowen $138 → $154 Maintains Market Perform
04/27/2023 30.32% Citigroup $150 → $165 Maintains Buy
04/27/2023 14.52% Stephens & Co. $140 → $145 Maintains Equal-Weight
04/27/2023 22.42% Deutsche Bank $145 → $155 Maintains Buy
04/27/2023 20.05% RBC Capital $130 → $152 Maintains Sector Perform
04/27/2023 28.74% Credit Suisse $153 → $163 Maintains Outperform
04/25/2023 12.16% Barclays $132 → $142 Upgrades Underweight → Equal-Weight
04/21/2023 12.95% Cantor Fitzgerald → $143 Initiates Coverage On → Underweight
04/19/2023 5.05% JP Morgan → $133 Initiates Coverage On → Neutral
03/06/2023 14.52% Deutsche Bank $168 → $145 Maintains Buy
03/06/2023 10.58% Mizuho $144 → $140 Maintains Buy
03/06/2023 9% Wells Fargo $154 → $138 Maintains Equal-Weight
03/03/2023 20.84% Credit Suisse $157 → $153 Maintains Outperform
03/01/2023 2.68% RBC Capital $114 → $130 Maintains Sector Perform
03/01/2023 10.58% Stephens & Co. $155 → $140 Maintains Equal-Weight
03/01/2023 — Wolfe Research Downgrades Outperform → Peer Perform
02/28/2023 22.42% Stephens & Co. → $155 Reiterates → Equal-Weight
01/24/2023 31.9% UBS $113 → $167 Upgrades Sell → Neutral
01/09/2023 4.26% Barclays $115 → $132 Maintains Underweight
01/03/2023 21.63% Wells Fargo → $154 Upgrades Underweight → Equal-Weight
12/16/2022 14.52% B of A Securities $120 → $145 Upgrades Underperform → Neutral
12/14/2022 13.74% Mizuho $126 → $144 Maintains Buy
11/25/2022 24% Credit Suisse $129 → $157 Maintains Outperform
11/02/2022 -0.48% Mizuho $121 → $126 Maintains Buy
10/27/2022 -9.96% SVB Leerink $98 → $114 Maintains Market Perform
08/24/2022 -9.17% SVB Leerink $111 → $115 Maintains Market Perform
07/28/2022 -12.33% SVB Leerink $103 → $111 Maintains Market Perform
07/27/2022 -9.96% RBC Capital $130 → $114 Maintains Sector Perform
07/15/2022 -18.65% SVB Leerink $108 → $103 Maintains Market Perform
07/12/2022 -13.12% Goldman Sachs $125 → $110 Maintains Sell
07/06/2022 -28.92% BMO Capital → $90 Downgrades Market Perform → Underperform
07/01/2022 11.37% Credit Suisse $156 → $141 Maintains Outperform
07/01/2022 -4.43% Mizuho $153 → $121 Maintains Buy
06/30/2022 -14.7% SVB Leerink $132 → $108 Maintains Market Perform
06/17/2022 -9.17% Loop Capital → $115 Initiates Coverage On → Hold
05/13/2022 4.26% SVB Leerink $139 → $132 Maintains Market Perform
05/03/2022 20.84% Mizuho $164 → $153 Maintains Buy
04/28/2022 -6.8% Wells Fargo $139 → $118 Maintains Underweight
04/27/2022 6.63% Stephens & Co. $150 → $135 Maintains Equal-Weight
04/27/2022 24.79% Credit Suisse $172 → $158 Maintains Outperform
04/27/2022 2.68% RBC Capital $149 → $130 Maintains Sector Perform
03/29/2022 9.79% Wells Fargo → $139 Initiates Coverage On → Underweight
03/07/2022 5.84% UBS $124 → $134 Maintains Sell
03/03/2022 29.53% Mizuho $151 → $164 Maintains Buy
02/28/2022 — Seaport Global Downgrades Buy → Neutral
02/28/2022 9.79% SVB Leerink $136 → $139 Maintains Market Perform
01/07/2022 7.42% SVB Leerink $132 → $136 Maintains Market Perform
12/21/2021 11.37% Barclays $160 → $141 Maintains Underweight
10/29/2021 19.26% Mizuho $178 → $151 Maintains Buy
10/27/2021 4.26% SVB Leerink $140 → $132 Maintains Market Perform
09/27/2021 10.58% SVB Leerink → $140 Initiates Coverage On → Market Perform
09/24/2021 7.42% UBS → $136 Initiates Coverage On → Sell
09/08/2021 18.47% Goldman Sachs $155 → $150 Downgrades Neutral → Sell
08/12/2021 23.21% Barclays $170 → $156 Downgrades Overweight → Underweight
07/28/2021 46.12% Deutsche Bank $160 → $185 Maintains Buy
07/27/2021 34.27% Barclays $160 → $170 Maintains Overweight
07/09/2021 34.27% Seaport Global → $170 Initiates Coverage On → Buy
06/10/2021 30.32% RBC Capital $160 → $165 Downgrades Outperform → Sector Perform
04/28/2021 26.37% RBC Capital $150 → $160 Maintains Outperform
04/19/2021 26.37% Deutsche Bank $145 → $160 Maintains Buy
01/05/2021 13.74% B of A Securities → $144 Downgrades Neutral → Underperform
09/21/2020 -9.17% JP Morgan $138 → $115 Downgrades Neutral → Underweight
07/29/2020 -7.59% Piper Sandler $113 → $117 Maintains Neutral
07/29/2020 10.58% Credit Suisse $139 → $140 Maintains Outperform
06/09/2020 9% Barclays → $138 Upgrades Equal-Weight → Overweight
04/30/2020 5.05% UBS $150 → $133 Maintains Buy
04/29/2020 6.63% Deutsche Bank $165 → $135 Maintains Buy
04/28/2020 1.1% Citigroup $157 → $128 Maintains Buy
04/23/2020 -10.75% Piper Sandler $141 → $113 Maintains Neutral
03/23/2020 — B of A Securities Downgrades Buy → Neutral
03/02/2020 22.42% JP Morgan $164 → $155 Maintains Neutral
02/28/2020 30.32% Baird $160 → $165 Maintains Outperform
02/28/2020 18.47% UBS $158 → $150 Maintains Buy
02/28/2020 19.26% Stephens & Co. $153 → $151 Maintains Equal-Weight
12/20/2019 29.53% JP Morgan $159 → $164 Maintains Neutral
10/28/2019 9% Barclays $145 → $138 Maintains Equal-Weight
07/31/2019 15.31% Morgan Stanley $135 → $146 Maintains Equal-Weight
04/17/2019 2.68% Barclays $136 → $130 Maintains Equal-Weight
03/04/2019 27.16% UBS $156 → $161 Maintains Buy
03/04/2019 — JP Morgan Downgrades Overweight → Neutral
03/01/2019 26.37% Deutsche Bank $140 → $160 Maintains Buy
03/01/2019 7.42% Barclays $130 → $136 Maintains Equal-Weight
03/01/2019 18.47% Wells Fargo $147 → $150 Maintains Outperform
03/01/2019 29.53% Citigroup $140 → $164 Maintains Buy
02/28/2019 14.52% Baird $140 → $145 Maintains Outperform
01/14/2019 — Stephens & Co. Initiates Coverage On → Equal-Weight
01/03/2019 10.58% Deutsche Bank → $140 Initiates Coverage On → Buy
12/14/2018 — Goldman Sachs Downgrades Neutral → Sell
10/29/2018 2.68% Morgan Stanley $134 → $130 Maintains Equal-Weight
10/29/2018 2.68% Barclays $135 → $130 Maintains Equal-Weight
10/29/2018 10.58% Citigroup $145 → $140 Maintains Buy
09/18/2018 22.42% B of A Securities $128 → $155 Upgrades Neutral → Buy
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
09/14/2023 16.89% 康託·菲茨傑拉德 →$148 重申 減碼→減碼
07/27/2023 33.48% 瑞士信貸 $163→$169 維護 跑贏大盤
07/26/2023 22.42% 斯蒂芬斯公司 →$155 重申 等重→等重
07/11/2023 34.27% 瑞穗 $150→$170 維護 買
06/02/2023 28.74% B of A證券 →$163 假設 中性→購買
2023年05月16日 9.79% 高盛 $124→$139 維護 賣
2023年05月16日 18.47% 瑞穗 $140→$150 維護 買
05/08/2023 21.63% TD Cowen $138→$154 維護 市場表現
04/27/2023 30.32% 花旗集團 $150→$165 維護 買
04/27/2023 14.52% 斯蒂芬斯公司 $140→$145 維護 等重
04/27/2023 22.42% 德意志銀行 $145→$155 維護 買
04/27/2023 20.05% 加拿大皇家銀行資本 $130→$152 維護 行業表現
04/27/2023 28.74% 瑞士信貸 $153→$163 維護 跑贏大盤
04/25/2023 12.16% 巴克萊 $132→$142 升級 重量不足的→等重
04/21/2023 12.95% 康託·菲茨傑拉德 →$143 開始承保 →減持
04/19/2023 5.05% 摩根大通 →$133 開始承保 →中性
03/06/2023 14.52% 德意志銀行 $168→$145 維護 買
03/06/2023 10.58% 瑞穗 $144→$140 維護 買
03/06/2023 9% 富國銀行 $154→$138 維護 等重
03/03/2023 20.84% 瑞士信貸 $157→$153 維護 跑贏大盤
03/01/2023 2.68% 加拿大皇家銀行資本 $114→$130 維護 行業表現
03/01/2023 10.58% 斯蒂芬斯公司 $155→$140 維護 等重
03/01/2023 - 沃爾夫研究 評級下調 超越→同行的表現
02/28/2023 22.42% 斯蒂芬斯公司 →$155 重申 →等重
01/24/2023 31.9% 瑞銀集團 $113→$167 升級 賣出→中性
01/09/2023 4.26% 巴克萊 $115→$132 維護 體重不足
01/03/2023 21.63% 富國銀行 →$154 升級 重量不足的→等重
12/16/2022 14.52% B of A證券 $120→$145 升級 表現不佳的→中性
2022年12月14日 13.74% 瑞穗 $126→$144 維護 買
2022年11月25日 百分之二十四 瑞士信貸 $129→$157 維護 跑贏大盤
11/02/2022 -0.48% 瑞穗 $121→$126 維護 買
10/27/2022 -9.96% SVB Leerink $98→$114 維護 市場表現
2022年08月24日 -9.17% SVB Leerink $111→$115 維護 市場表現
07/28/2022 -12.33% SVB Leerink $103→$111 維護 市場表現
07/27/2022 -9.96% 加拿大皇家銀行資本 $130→$114 維護 行業表現
07/15/2022 -18.65% SVB Leerink $108→$103 維護 市場表現
07/12/2022 -13.12% 高盛 $125→$110 維護 賣
07/06/2022 -28.92% 蒙特利爾銀行資本 →$90 評級下調 市場表現→表現不佳
07/01/2022 11.37% 瑞士信貸 $156→$141 維護 跑贏大盤
07/01/2022 -4.43% 瑞穗 $153→$121 維護 買
2022/06/30 -14.7% SVB Leerink $132→$108 維護 市場表現
06/17/2022 -9.17% 環路資本 →$115 開始承保 →保留
2022年05月13日 4.26% SVB Leerink $139→$132 維護 市場表現
05/03/2022 20.84% 瑞穗 $164→$153 維護 買
04/28/2022 -6.8% 富國銀行 $139→$118 維護 體重不足
04/27/2022 6.63% 斯蒂芬斯公司 $150→$135 維護 等重
04/27/2022 24.79% 瑞士信貸 $172→$158 維護 跑贏大盤
04/27/2022 2.68% 加拿大皇家銀行資本 $149→$130 維護 行業表現
03/29/2022 9.79% 富國銀行 →$139 開始承保 →減持
03/07/2022 5.84% 瑞銀集團 $124→$134 維護 賣
03/03/2022 29.53% 瑞穗 $151→$164 維護 買
02/28/2022 - 環球海港 評級下調 購買→中性
02/28/2022 9.79% SVB Leerink $136→$139 維護 市場表現
01/07/2022 7.42% SVB Leerink $132→$136 維護 市場表現
2021/12/21 11.37% 巴克萊 $160→$141 維護 體重不足
10/29/2021 19.26% 瑞穗 $178→$151 維護 買
10/27/2021 4.26% SVB Leerink $140→$132 維護 市場表現
09/27/2021 10.58% SVB Leerink →$140 開始承保 →市場表現
09/24/2021 7.42% 瑞銀集團 →$136 開始承保 →銷售
09/08/2021 18.47% 高盛 $155→$150 評級下調 中性→銷售
2021/08/12 23.21% 巴克萊 $170→$156 評級下調 增持→減持
07/28/2021 46.12% 德意志銀行 $160→$185 維護 買
07/27/2021 34.27% 巴克萊 $160→$170 維護 超重
07/09/2021 34.27% 環球海港 →$170 開始承保 →購買
2021/10/06 30.32% 加拿大皇家銀行資本 $160→$165 評級下調 跑贏→板塊表現
04/28/2021 26.37% 加拿大皇家銀行資本 $150→$160 維護 跑贏大盤
04/19/2021 26.37% 德意志銀行 $145→$160 維護 買
01/05/2021 13.74% B of A證券 →$144 評級下調 中性→表現不佳
2020/09/21 -9.17% 摩根大通 $138→$115 評級下調 中性→減持
07/29/2020 -7.59% 派珀·桑德勒 $113→$117 維護 中性
07/29/2020 10.58% 瑞士信貸 $139→$140 維護 跑贏大盤
06/09/2020 9% 巴克萊 →$138 升級 等重→超重
04/30/2020 5.05% 瑞銀集團 $150→$133 維護 買
04/29/2020 6.63% 德意志銀行 $165→$135 維護 買
04/28/2020 1.1% 花旗集團 $157→$128 維護 買
04/23/2020 -10.75% 派珀·桑德勒 $141→$113 維護 中性
03/23/2020 - B of A證券 評級下調 購買→中性
03/02/2020 22.42% 摩根大通 $164→$155 維護 中性
02/28/2020 30.32% 貝爾德 $160→$165 維護 跑贏大盤
02/28/2020 18.47% 瑞銀集團 $158→$150 維護 買
02/28/2020 19.26% 斯蒂芬斯公司 $153→$151 維護 等重
2019年12月20日 29.53% 摩根大通 $159→$164 維護 中性
2019年10月28日 9% 巴克萊 $145→$138 維護 等重
2019年07月31日 15.31% 摩根士丹利 $135→$146 維護 等重
2019/04/17 2.68% 巴克萊 $136→$130 維護 等重
2019/03/04 27.16% 瑞銀集團 $156→$161 維護 買
2019/03/04 - 摩根大通 評級下調 超重→中性
2019年03月01日 26.37% 德意志銀行 $140→$160 維護 買
2019年03月01日 7.42% 巴克萊 $130→$136 維護 等重
2019年03月01日 18.47% 富國銀行 $147→$150 維護 跑贏大盤
2019年03月01日 29.53% 花旗集團 $140→$164 維護 買
2019年02月28日 14.52% 貝爾德 $140→$145 維護 跑贏大盤
2019年01月14日 - 斯蒂芬斯公司 開始承保 →等重
2019年03月01日 10.58% 德意志銀行 →$140 開始承保 →購買
2018年12月14日 - 高盛 評級下調 中性→銷售
2018年10月29日 2.68% 摩根士丹利 $134→$130 維護 等重
2018年10月29日 2.68% 巴克萊 $135→$130 維護 等重
2018年10月29日 10.58% 花旗集團 $145→$140 維護 買
2018年09月18日 22.42% B of A證券 $128→$155 升級 中性→購買

What is the target price for Universal Health Servs (UHS)?

Universal Health Serv(UHS)的目標價格是多少？

The latest price target for Universal Health Servs (NYSE: UHS) was reported by Cantor Fitzgerald on September 14, 2023. The analyst firm set a price target for $148.00 expecting UHS to rise to within 12 months (a possible 16.89% upside). 32 analyst firms have reported ratings in the last year.

Cantor Fitzgerald於2023年9月14日報道了Universal Health Serv(紐約證券交易所代碼：UHS)的最新目標價。這家分析公司將目標價定為148.00美元，預計UHS將在12個月內上漲至16.89%(可能上漲16.89%)。去年有32家分析公司公佈了評級。

What is the most recent analyst rating for Universal Health Servs (UHS)?

分析師對Universal Health Serv(UHS)的最新評級是多少？

The latest analyst rating for Universal Health Servs (NYSE: UHS) was provided by Cantor Fitzgerald, and Universal Health Servs reiterated their underweight rating.

環球健康服務公司(紐約證券交易所代碼：UHS)的最新分析師評級由Cantor Fitzgerald提供，環球健康服務公司重申其減持評級。

When is the next analyst rating going to be posted or updated for Universal Health Servs (UHS)?

Universal Health Serv(UHS)的下一次分析師評級將於何時發佈或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Universal Health Servs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Universal Health Servs was filed on September 14, 2023 so you should expect the next rating to be made available sometime around September 14, 2024.

分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Universal Health Serv的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Universal Health Serv的上一次評級是在2023年9月14日提交的，因此您應該預計下一次評級將在2024年9月14日左右提供。

Is the Analyst Rating Universal Health Servs (UHS) correct?

分析師對Universal Health Serv(UHS)的評級正確嗎？

While ratings are subjective and will change, the latest Universal Health Servs (UHS) rating was a reiterated with a price target of $0.00 to $148.00. The current price Universal Health Servs (UHS) is trading at is $126.61, which is within the analyst's predicted range.

雖然評級是主觀的，並將發生變化，但最新的Universal Health Serv(UHS)評級被重申，目標價在0.00美元至148.00美元之間。Universal Health Serv目前的交易價格為126.61美元，在分析師的預測範圍內。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論